Literature DB >> 21449672

Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.

Patrick Kwan1, Virginia Wong, Ping Wing Ng, Colin Hiu Tung Lui, Ngai Chuen Sin, Ka Sing Wong, Larry Baum.   

Abstract

AIM: To determine the association between polymorphisms of the multidrug transporter genes ABCC2, ABCC5 and ABCG2, and drug resistance in epilepsy by genotyping comprehensive sets of tagging SNPs. MATERIALS &
METHODS: A total of 25 tagging SNPs from ABCC2, ABCC5 and ABCG2 genes were genotyped in a total of 590 Han Chinese epilepsy patients (262 drug resistant and 328 drug responsive). Genotype and allele distributions in drug-responsive and drug-resistant patients were compared.
RESULTS: Genotype distributions of all the selected SNPs were consistent with Hardy-Weinberg equilibrium. None of the polymorphisms, either genotype or allele distributions, were significantly associated with drug resistance. For each gene, no haplotypes of over 1% frequency, and that included all SNPs of the gene, were associated with drug resistance.
CONCLUSION: This gene-wide tagging study revealed no association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449672     DOI: 10.2217/pgs.10.183

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  9 in total

1.  Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.

Authors:  Jessica K Roberts; Anna V Birg; Tong Lin; Vinay M Daryani; John C Panetta; Alberto Broniscer; Giles W Robinson; Amar J Gajjar; Clinton F Stewart
Journal:  Drug Metab Dispos       Date:  2016-04-06       Impact factor: 3.922

2.  Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2.

Authors:  Lenka Slachtova; Ondrej Seda; Jana Behunova; Martin Mistrik; Pavel Martasek
Journal:  Eur J Hum Genet       Date:  2015-09-09       Impact factor: 4.246

Review 3.  The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.

Authors:  Pin Chen; Qing Yan; Haitao Xu; Ailin Lu; Peng Zhao
Journal:  Genet Test Mol Biomarkers       Date:  2013-12-10

4.  Effects of various genetic polymorphisms on thiopurine treatment-associated outcomes for Korean patients with Crohn's disease.

Authors:  Rihwa Choi; Mi-Na Lee; Kyunga Kim; Sun-Young Baek; Tae Jun Kim; Sung Noh Hong; Young-Ho Kim; Soo-Youn Lee
Journal:  Br J Clin Pharmacol       Date:  2020-06-01       Impact factor: 4.335

5.  Common variants of KCNJ10 are associated with susceptibility and anti-epileptic drug resistance in Chinese genetic generalized epilepsies.

Authors:  Yong Guo; Kui Po Yan; Qiang Qu; Jian Qu; Zi Gui Chen; Tao Song; Xiang-Ying Luo; Zhong-Yi Sun; Chang-Long Bi; Jin-Fang Liu
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 6.  Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.

Authors:  Malek Chouchi; Wajih Kaabachi; Hedia Klaa; Kalthoum Tizaoui; Ilhem Ben-Youssef Turki; Lamia Hila
Journal:  BMC Neurol       Date:  2017-02-15       Impact factor: 2.474

Review 7.  Pharmacogenetics of antiepileptic drugs: A brief review.

Authors:  D Parker; E J Sanders; K J Burghardt
Journal:  Ment Health Clin       Date:  2016-03-08

8.  Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients.

Authors:  Laith N Al-Eitan; Islam M Al-Dalalah; Mohamed M Mustafa; Mansour A Alghamdi; Afrah K Elshammari; Wael H Khreisat; Hanan A Aljamal
Journal:  Pharmgenomics Pers Med       Date:  2019-06-10

9.  Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance.

Authors:  Shabeesh Balan; Sumitha Prameela Bharathan; Neetha Nanoth Vellichiramal; Sanish Sathyan; Vijai Joseph; Kurupath Radhakrishnan; Moinak Banerjee
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.